Rhinocort vs Sudafed:Which is more popular?
In September 2026, Sudafed had more branded searches than Rhinocort among nasal spray brands in New Zealand. Sudafed had about 5,500 branded searches, while Rhinocort had 60. Sudafed made up 57.5% of all nasal spray brand searches we track, and Rhinocort accounted for 0.63%. When we asked ChatGPT and Google AI Overviews about nasal spray brands, neither Rhinocort nor Sudafed appeared in any of the five answers.
Who do people search for more?
Sudafed, about 92 searches for every 1 for Rhinocort
Who does AI mention more?
Both were mentioned in 0 of 5 answers.
Follow Rhinocort vs Sudafed and get free monthly updates on what changed
By continuing you'll get index updates and occasional product news from Brandwave. Unsubscribe any time. Privacy
Top nasal spray brands in ChatGPT and Google AI Overviews
In three ChatGPT questions and two Google AI Overviews, neither Rhinocort nor Sudafed showed up in any of the five answers.
Most recommended by AI
Brands get a higher ranking if they are mentioned earlier in the answers.
Mentioned by AI
Each dot is one answer, filled in when that answer mentions the brand.
See every answer about nasal spray brands
5 answers
Asked ChatGPT
“Which nasal spray brand should I buy in New Zealand?”
Asked ChatGPT
“What are the best nasal spray brands in New Zealand?”
Asked ChatGPT
“What's the best nasal spray brand in New Zealand for blocked nose?”
Searched Google, AI Overview
“nasal spray nz”
- 1
Fess
- 1
Searched Google, AI Overview
“hay fever spray”
Brands are shown in the order each answer named them. The survey took place in New Zealand on October 21, 2026.
Is Rhinocort or Sudafed more popular in search?
This chart shows how often people search Google for Rhinocort and Sudafed by name. Each line represents a brand's share of searches for all four nasal spray brands we track, month by month, from searches in New Zealand.
Share of searches by month for Sudafed, Rhinocort. The figures are in the table below the chart.
View monthly share of searches table
| Month | Sudafed | Otrivin | Fess | Rhinocort |
|---|---|---|---|---|
| Oct 2025 | 58.1% | 30.7% | 10.7% | 0.53% |
| Nov 2025 | 52.2% | 34.6% | 12.3% | 0.87% |
| Dec 2025 | 52.3% | 34.1% | 11.8% | 1.8% |
| Jan 2026 | 53.3% | 32.1% | 13.4% | 1.1% |
| Feb 2026 | 55.7% | 30.7% | 12.5% | 1.2% |
| Mar 2026 | 55.4% | 32.9% | 11% | 0.76% |
| Apr 2026 | 56.9% | 30.9% | 11.4% | 0.77% |
| May 2026 | 56.3% | 33.9% | 9% | 0.85% |
| Jun 2026 | 56.1% | 33.3% | 9.5% | 1.1% |
| Jul 2026 | 59.3% | 30.3% | 9.6% | 0.87% |
| Aug 2026 | 58.8% | 30.9% | 9.8% | 0.5% |
| Sep 2026 | 57.5% | 30.3% | 11.6% | 0.63% |
How has the Rhinocort and Sudafed comparison changed over the last 12 months?
3 findings
- Sudafed was ahead of Rhinocort in every measured month of the 12 months ending September 2026.
- Across the 12 months ending September 2026, Rhinocort’s share of searches among nasal spray brands in New Zealand moved from 0.53% to 0.63%, and its estimated monthly branded searches moved from 40 to 60.
- Across the 12 months ending September 2026, Sudafed’s share of searches among nasal spray brands in New Zealand moved from 58.1% to 57.5%, and its estimated monthly branded searches moved from 4.3K to 5.5K.
How did search popularity change for New Zealand nasal spray brands in September 2026?
2 changes
In September 2026, Sudafed lost share of searches among nasal spray brands in New Zealand, from 58.8% to 57.5%.
Estimated monthly branded searches for Rhinocort in New Zealand rose 50% over 12 measured months, from 40 to 60 in September 2026.
How are branded searches counted?
10 search terms
Brandwave collects information about searches that people make online using Rhinocort’s and Sudafed’s names. When viewed over time, estimated search volumes for these branded terms can be used to understand whether interest in the brands is growing, holding steady, or fading.
Other head-to-heads among nasal spray brands
Put your own brand in this comparison
Brandwave tracks your branded demand next to the rival you actually watch, with your campaigns, spend and outcomes on the same timeline.